Fig. 2From: Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry studyLongitudinal progression of HFMSE score. HFMSE score for younger sitters (blue), older sitters (red), lost sitters (yellow), and lost walkers (green). Data are listed as mean and 99% confidence interval. Available patients at baseline, m14, m26 and m38 are added. For a group size fewer than 10 patients no data are depictedBack to article page